DOP rejects Mylan review application for revising retail price of Hepatitis B, HIV drug Farhat Nasim18 July 2019 3:58 PM ISTNew Delhi: Through a recent decision, the Department of Pharmaceuticals has rejected the review application filed by Mylan Pharmaceuticals Private...
Patients with NASH have been enrolled in 3 phase III trials of Saroglitazar, says Zydus Cadila Medical Dialogues Bureau18 July 2019 9:17 AM IST"Patients with NASH have been enrolled in these trials across clinical sites in India and Mexico," Cadila Healthcare, the listed entity of the group,...
Cancer Drug Patent Issues: Delhi HC junks Bayer plea to block Natco Pharma Regonat Farhat Nasim15 July 2019 2:52 PM ISTNew Delhi: The Delhi High Court recently junked the injunction petition filed by the German Drugmaker to restrain the Hyderabad-based Natco Pharma...
Sun Pharma unveils Ezallor Sprinkle capsules for treating lipid disorder in US Farhat Nasim15 July 2019 2:40 PM ISTEzallor Sprinkle (rosuvastatin) capsules are indicated for three types of lipid disorders in conjunction with diet in adults, Sun Pharma said in a...
Lupin to focus on launch of biosimilar, inhalation product in US this fiscal Medical Dialogues Bureau15 July 2019 9:45 AM ISTCoupling this with the building of Solosec brand in the US, NaMuscla in Europe and Bipresso in Japan will help Lupin drive sustainable growth, they...
Torrent Pharma, Glenmark enter agreement to market Remogliflozin under trademark Zucator in India Medical Dialogues Bureau11 July 2019 10:00 AM IST"Glenmark will manufacture and supply Remogliflozin while Torrent will market the drug under its own trademark 'Zucator' in India," Glenmark Pharma...
Lupin unveils generic Imatinib Mesylate tablets to treat types of cancer Medical Dialogues Bureau10 July 2019 10:00 AM ISTLupin's Imatinib Mesylate Tablets, 100mg (base) and 400mg (base), is the generic version of Novartis Pharmaceuticals Corporation's (Novartis) Gleevec...
Drug Alert: CDSCO declares 26 drug samples as sub-standard in quality in random sampling; Details Farhat Nasim8 July 2019 4:16 PM ISTNew Delhi: Apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared more than a dozen drugs as sub-standard in...
Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy Medical Dialogues Bureau8 July 2019 1:32 PM ISTAs part of the diversification and new market entry strategy, DRL (Dr Reddys) plans to re-focus some of its Research and Development resources to...
SAARC nations favour India-based Haslab for Homoeopathic Medicines Medical Dialogues Bureau6 July 2019 9:45 AM ISTHaslab as they are known in the homoeopathy market, they provide various forms of homoeopathic products like eye drops, homoeopathic complex tablets,...
Single dose of Xofluza flu drug as effective as Tamiflu in kids, says Roche Medical Dialogues Bureau6 July 2019 9:15 AM ISTXofluza, an oral treatment, was well tolerated in children, said Roche, whose medicine is already approved broadly in Japan and for people older than...
Zydus Cadila gets USFDA nod for generic Misoprostol tablets to treat ulcers Medical Dialogues Bureau5 July 2019 11:52 AM ISTNew Delhi: Drug firm Zydus Cadila Wednesday said it has received the final nod from the US health regulator to market its generic Misoprostol tablets...
